ZYVERSA THERAPEUTICS, INC. Shares Outstanding (Cover Page)
ZYVERSA THERAPEUTICS, INC. (ZVSA) had Shares Outstanding (Cover Page) of 8.10 million shares as of 2026-05-11, per its 10-Q filed 2026-05-13.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-05-13
- 2026-05-11: Entity Common Stock, Shares Outstanding 8.10M shares.
- 2026-03-25: Entity Common Stock, Shares Outstanding 8.10M shares.
- 2025-11-17: Entity Common Stock, Shares Outstanding 8.10M shares.
- 2025-08-07: Entity Common Stock, Shares Outstanding 8.10M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-05-11 | 8.10M shares 10-Q · filed 2026-05-13 |
| 2026-03-25 | 8.10M shares 10-K · filed 2026-03-31 |
| 2025-11-17 | 8.10M shares 10-Q · filed 2025-11-19 |
| 2025-08-07 | 8.10M shares 10-Q · filed 2025-08-13 |
| 2025-05-07 | 4.77M shares 10-Q · filed 2025-05-12 |
| 2025-03-20 | 2.57M shares 10-K · filed 2025-03-27 |
| 2024-11-11 | 2.34M shares 10-Q · filed 2024-11-14 |
| 2024-08-08 | 1.03M shares 10-Q · filed 2024-08-09 |
| 2024-05-10 | 834.90K shares 10-K/A · filed 2024-05-15 |
| 2024-03-21 | 7.59M shares 10-K · filed 2024-03-25 |
| 2023-11-10 | 43.52M shares 10-Q · filed 2023-11-14 |
| 2023-08-16 | 30.89M shares 10-Q · filed 2023-08-21 |
| 2023-05-10 | 20.23M shares 10-Q · filed 2023-05-12 |
| 2023-03-23 | 9.21M shares 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |